Immune system defects are at the center of aging and a range of diseases. Here, we show that prolonged fasting reduces circulating IGF-1 levels and PKA activity in various cell populations, leading to signal transduction changes in long-term hematopoietic stem cells (LT-HSCs) and niche cells that promote stress resistance, self-renewal, and lineage-balanced regeneration. Multiple cycles of fasting abated the immunosuppression and mortality caused by chemotherapy and reversed age-dependent myeloid-bias in mice, in agreement with preliminary data on the protection of lymphocytes from chemotoxicity in fasting patients. The proregenerative effects of fasting on stem cells were recapitulated by deficiencies in either IGF-1 or PKA and blunted by exogenous IGF-1. These findings link the reduced levels of IGF-1 caused by fasting to PKA signaling and establish their crucial role in regulating hematopoietic stem cell protection, selfrenewal, and regeneration.
INTRODUCTION
Prolonged fasting (PF) lasting 48-120 hr reduces progrowth signaling and activates pathways that enhance cellular resistance to toxins in mice and humans (Fontana et al., 2010; Guevara-Aguirre et al., 2011; Holzenberger et al., 2003; Lee and Longo, 2011; Longo et al., 1997) . The physiological changes caused by PF are much more pronounced than those caused by calorie restriction or fasting lasting 24 hours or less in part because of the requirement to fully switch to a fat-and ketone bodies-based catabolism after glycogen reserves are depleted during PF (Longo and Mattson, 2014) . Studies in mice indicate that PF can protect them from chemotoxicity by reducing circulating insulin-like growth factor-1 (IGF-1) (Lee et al., 2010; Raffaghello et al., 2008) . A preliminary case series study also indicates that PF has the potential to ameliorate several side effects caused by chemotherapy in humans (Safdie et al., 2009) . One of the side effects, myelosuppression, is often dose limiting in chemotherapy treatment, in part because damage to adult stem/progenitor cells impairs tissue repair and regeneration (Kofman et al., 2012; Mackall et al., 1994; van Tilburg et al., 2011; Williams et al., 2004) . Despite the rising interest in nutrient-dependent changes in stem cell populations, little is known about how acute or periodic dietary interventions affect the hematopoietic system. Hematopoietic stem and progenitor cells (HSPCs) residing in the adult bone marrow (BM) are part of the Lin (Challen et al., 2009; Rathinam et al., 2011) . Together, these cells are responsible for adult hematopoietic regeneration. In the heterogeneous hematopoietic stem cells (HSCs), several subtypes are identified as lymphoid-(Ly-HSCs), balanced HSC (Bala-HSC), and myeloidHSCs (My-HSCs) according to their distinct mature blood cell outputs ( Figure S1 ) (Benz et al., 2012; Challen et al., 2010; Muller-Sieburg et al., 2004) . In both mice and humans, these HSC subtypes modulate hematopoietic lineage potential and play an important role in lineage-homeostasis during aging (Beerman et al., 2010; Challen et al., 2010; Cho et al., 2008; Pang et al., 2011) . Here, we studied the role of multiple PF cycles on chemotherapy-induced and age-dependent immunosuppression and investigated how PF affects HSC self-renewal, the Ly-, My-, and Bala-HSC subtypes as well as their hematopoietic reconstitution outcomes.
RESULTS

Cycles of Prolonged Fasting Reduce Damage in Bone Marrow Stem and Progenitor Cells and Protect Mice against Chemotoxicity
Chemotherapy drugs cause immunosuppression by inducing DNA damage and cell death in both peripheral blood (PB) and bone marrow (BM), which often results in the long-term impairment of hematopoiesis (Bedford et al., 1984; Yahata et al., 2011) . To test whether PF may protect the hematopoietic system against immunosuppressive toxicity, mice were fasted or fed an ad libitum diet (AL) and then challenged with cyclophosphamide (CP) for multiple cycles ( Figure 1A ) (Adams et al., 2007) . In agreement with our previous results with etoposide and doxorubicin, we observed a major protective effect of cycles of 48 hr PF against CP-induced mortality (Figures 1B and S1A) (Raffaghello et al., 2008) . The PF cycles also led to a decrease in the DNA damage caused by CP in leukocytes and BM cells (Figures 1C and S1B) .
To determine whether PF can protect from chemotherapyinduced toxicity, we collected BM cells at the end of six cycles of CP or PF + CP treatments and measured apoptosis. Given that the HSPCs represent a minor fraction of the total BM, we further examined apoptosis in the subpopulations of these cells (i.e., LT-HSCs, ST-HSCs, and MPPs) by performing TUNEL assay. The results indicate that without affecting BM cellularity, PF diminished CP-induced apoptosis in HSPCs (p < 0.05, t test), particularly in ST-HSCs and MPPs ( Figures 1D, S1C , and S1D). The PF-induced protection against CP-induced apoptosis was also confirmed by Annexin V binding assay for HSPCs ( Figure S1E ).
Prolonged Fasting Cycles Promote Lineage-Balanced Hematopoietic Regeneration
To assess whether the protection of HSPCs improved the hematopoietic recovery, we compared the hematological profiles of CP and PF + CP mice at baseline (before CP treatments, after PF), at nadir (2-4 days after CP) and during the recovery phase (8-10 days after CP) for each cycle of chemotherapy. Multicycle CP treatments resulted in a major decline in white blood cell (WBC) counts ( Figure 1E ). In the control group, WBC suppression, especially the number of lymphocytes, persisted for more than 70 days (six cycles) ( Figure 1E ). PF reduced WBC counts independently of chemotherapy and did not prevent the CP-induced decrease in the number of WBCs ( Figure 1E , time 0). However, the beneficial effect of PF was evident starting on cycle 4 (day 39) followed by the return of lymphocytes to normal levels after the fifth cycle (day 56) (Figure 1E ). At the end of six cycles of treatment, mice in the PF group also showed normal or close to normal levels of lymphoid cells and normal ratios of lymphoid and myeloid cells (L/M) ( Figure 1E , right panel). This recovery was observed at similar time points in three independent experiments (n = 20).
To begin to determine whether PF cycles can potentially promote a similar effect in humans, we also analyzed the hematological profiles of cancer patients from a phase I clinical trial for the feasibility and safety of a 24-72 hr PF period in combination with chemotherapy. Although three different platinum-based drug combinations were used (Table S1) , the results from a phase I clinical trial indicate that 72 but not 24 hr of PF in combination with chemotherapy were associated with normal lymphocyte counts and maintenance of a normal lineage balance in WBCs ( Figure 1F ). These encouraging preliminary results will need to be expanded and confirmed in the ongoing phase II randomized phase of the clinical trial.
In agreement with the effect of PF on the recovery in WBC numbers and improvement in lymphoid/myeloid ratio, results of fluorescence-activated cell sorting (FACS) analyses for stem cell populations indicated an improved preservation of LTHSCs and ST-HSCs and the enhanced resistance to the myeloid bias in the PF group after six cycles of CP treatment in mice (Figures 1G and 1H) .
To assess whether the increased HSCs in BM from PF + CP mice can enhance hematopoietic regeneration, we collected BM cells from the CP-or PF + CP-treated mice and transplanted the same number of cells into the immunocompromised (irradiated) recipient mice. Results of this competitive repopulation assay indicate that, compared to the control group fed ad libitum, the BM cells from mice exposed to six cycles of CP treatment preceded by PF have higher regeneration capacity leading to efficient blood reconstitution with normal lymphoid/myeloid ratio (L/M), as evident from the improved engraftment in the blood and BM ( Figures 1I, S1G , and S1H).
Prolonged Fasting Cycles Regulate Stem Cells Independently of Chemotherapy and Help Reverse Immunosenescence
We tested whether the cycles of PF alone could also stimulate HSC self-renewal. Results using bromodeoxyuridine (BrdU) incorporation assays indicated an approximately 6-fold increase of newly generated (BrdU + ) HSPCs (i.e., LT-HSC, ST-HSC, and MPP) in PF mice, which represents 93.7% of the total increase in HSPCs after PF cycles ( Figure 2A ). We found that the increase in LSK cell number is due mainly to an increase in LT-HSCs and STHSCs ( Figure 2B ). By contrast, the number of total BM cells and that of progenitors (i.e., MPP, multipotent progenitors; CLP, common lymphoid progenitors; CMP, common myeloid progenitor) was not increased by PF, and, in fact, the number of CMP was slightly decreased during PF ( Figures 2C and S2A) .
Results from cell-cycle analyses indicate that PF alone induced a major increase of S/G2/M phase LT-HSCs, ST-HSCs, and MPPs ( Figure 2D ). The significant induction in cell-cycle entry could explain at least part of the PF-induced increase in HSCs. In addition to the Ki67/Hoechst 33342 staining for cell-cycle analysis, the PF-induced self-renewal proliferation was confirmed by analysis using Pyronin Y/Hoechst 33342 staining ( Figure S2B ). On the other hand, results from the TUNEL assay indicate that apoptosis was barely detectable in any subpopulation of HSPCs from either AL-fed or PF mice when no chemotherapy treatment was applied. Apoptosis analysis using Annexin V and 7AAD indicate similar results ( Figure S2C ). Although PF alone reduces the apoptosis rate in ST-HSCs significantly, the small reduction (from 1.57% to 0.72%) in apoptosis/cellular death could only contribute to a very small portion of the PF-induced increase in HSCs and MPP ( Figure 2E ). However, because studies of HSCs have shown that induction of proliferation may sometimes be accompanied by an increase of apoptosis (Nakada et al., 2010; Tothova et al., 2007) , it is important to note that this was not observed in PF-induced self-renewal proliferation.
Besides the increase in the number of HSCs and MPP, we also observed a PF-dependent alteration of lymphoid-, (legend continued on next page)
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Fasting Inhibits IGF-1/PKA to Promote Regeneration myeloid-biased, and balanced-HSCs ratio ( Figures 2F, S2D , and S2E). Whereas most HSCs from young mice are balanced in lymphopoiesis and myelopoiesis, the majority of HSCs from elderly mice are myeloid biased (Beerman et al., 2010; Challen et al., 2010; Cho et al., 2008; Dykstra et al., 2007; Morita et al., 2010; Muller-Sieburg et al., 2004; Pang et al., 2011) . We therefore investigated if PF cycles can correct this bias in aged mice.
Results from 18-month-old mice indicate that eight cycles of PF could reverse the age-dependent myeloid bias in HSC subtypes and reverse the effect of aging on WBC number in whole blood (Figures 2F and 2G) , similar to the changes observed in mice and possibly patients undergoing PF in combination with chemotherapy ( Figures 1E, 1F , and 1H). Taken together, these results suggest that PF cycles can also stimulate the HSCs in a chemotherapy-independent manner, which leads to a lineage-balanced hematopoietic regeneration.
Mimicking the Effects of Prolonged Fasting by Deficiency in GHR/IGF-1 Signaling Promotes Hematopoietic Recovery
We previously showed that PF reduces circulating IGF-1 levels and that IGF-I deficiency is sufficient to protect mice against chemotherapy toxicity (Lee et al., 2010) . To determine whether the improved hematopoietic regeneration caused by PF in mice can be replicated by IGF-1 deficiency, we studied the hematopoietic system in growth hormone receptor knockout (GHRKO) mice, which have very low circulating and BM IGF-1 levels (Al-Regaiey et al., 2005) (Figures 3A and S3A; Table S2 ). We found that CPinduced DNA damage measured by the comet assay in PB and BM cells of GHRKO mice was significantly reduced compared to that in cells from wild-type littermates ( Figure 3B ). Similar to what was observed in mice undergoing pre-chemo PF cycles, STHSCs of the GHRKO mice were protected from CP-induced apoptosis ( Figure 3C ). Also, the number of HSCs (i.e., LT-HSCs and ST-HSCs) preserved in the BM of GHRKO mice was higher than that in the wild-type littermates ( Figure 3D ). An improvement in hematopoietic recovery analogous to that caused by PF was also observed in GHRKO mice ( Figure 3E ). We found that IGF-1 deficiency also caused the protective effects and the regenerative effects independently of chemotoxicity. Unlike PF mice, GHRKO mice did not have higher levels of total HSPCs ( Figure S3B ). However, similarly to what we observed after PF cycles, the levels of HSCs (i.e., LT-HSCs plus ST-HSCs) was significantly higher in GHRKO mice compared to those in age-and sex-matched littermates, with increased cell-cycle entry but no detectable differences in apoptosis ( Figures 3F, 3G , and S3C-S3E). Also, the age-dependent myeloid bias was not observed in the GHRKO mice ( Figure 3H ). These data suggest that the periodically reduced IGF-1 signaling caused by PF cycles may play a crucial role in the hematopoietic regeneration observed in mice.
Prolonged Fasting Promotes Hematopoietic
Regeneration in a IGF-1/PKA-Dependent Manner To understand the molecular mechanism by which PF and GHR/ IGF-1 deficiency promote hematopoietic recovery/regeneration, we reanalyzed two of our previously published microarray data sets and looked for genes whose expression significantly changed in response to PF with a focus on genes similarly affected by exposure of epithelial cells to IGF-1-deficient serum (GuevaraAguirre et al., 2011; Kim and Volsky, 2005; Kirschner et al., 2009; Lee et al., 2012) . In starved mice, the expression of the PKA catalytic subunit alpha (PKACa) was significantly reduced in all tissues tested (Table S3) . Similarly, IGF-1-deficient serum from growth hormone receptor-deficient (GHRD) human subjects caused changes in the expression of both positive and negative regulators of PKA consistent with an inhibition of its kinase activity (Table S4) .
As PKA phosphorylates the cAMP response element-binding transcription factor (CREB) at Ser133, p-CREB is commonly used as an indicator of intracellular PKA activity (Gonzalez and Montminy, 1989) . Using mouse embryonic fibroblasts devoid of the endogenous IGF-1 receptor (R-cells) and those overexpressing the human IGF1R (R + cell), we showed that CREB phosphorylation is positively regulated by IGF-1/IGF-1R in a PKA-dependent manner, confirming the link between IGF-1 and PKA/CREB signaling in mammalian cells ( Figure 4A ). IGF-1 receptor (IGF-1R) expression, which was higher in progenitor cells compared to LT-HSCs (Venkatraman et al., 2013) , was not affected by PF ( Figure S4A ). Taken together, our in vivo results indicate that PF reduces PKA signaling in BM cells at least in part through reduced IGF-1 levels, but without affecting IGF-1R expression ( Figure 4B ). 
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To demonstrate that IGF-1 is a mediator of PF-dependent effects on HSCs, we tested whether exogenous IGF-1 can blunt the effect of PF on HSC number and PKA activity. Fasted mice were injected with IGF-1 (200 mg/kg) to reverse the reduction of IGF-1 during PF. Results indicate that IGF-1 administration significantly blunted PF-induced reduction of PKA/pCREB in the LSK population, particularly in HSCs ( Figure 4C ). It also blunted the PF-induced increase in HSCs but not in MPPs ( Figure 4D ; Table S4 ). We further investigated whether the induction in HSCs can lead to enhanced engraftment and whether this effect is IGF-1/PKA dependent. Results of competitive repopulation assays indicate the PF improved hematopoietic reconstitution in PB and in BM. This effect was blocked by exogenous IGF-1 ( Figures  4E, 4F, S4B, and S4C) . Results of secondary transplantation further confirmed the effects in long-term repopulation capacity ( Figures 4G and 4H) . Overall, these results strongly support a role for lower IGF-1 and the consequent reduced activity of PKA in PF-dependent stimulation of HSC self-renewal and the improvement in both short-and long-term hematopoietic repopulation capacities ( Figures 4E-4H) .
Because IGF-1R signaling and IGF-1 expression were both reduced in the BM stromal niche cells (Lin Figure 5A ), we investigated whether the stromal niche could play a role in promoting PF-induced HSC self-renewal by reducing IGF-1 levels in the microenvironment (as previously shown in Figure 3A) . To test this, LT-HSCs were purified (CD45 + LSK CD150 + CD48 À ) from mice on either PF or the control diet and then cross-exposed to the stromal niche cells (CD45 À Lin À fraction) from mice on either PF or the ad lib diet using coculture systems ( Figure 5B ). Notably, LT-HSCs are unable to survive in the absence of niche cells, so the isolated LT-HSCs were not studied alone. Results indicate that the effect of PF on LT-HSC is sufficient to promote the self-renewal of LT-HSC and its capacity to generate ST-HSC and non-LSK progenitors (Linnon-LSK) ( Figure 5C , comparing A to B, C to D). Also, the PFtreated niche cells could increase the generation of ST-HSCs from ad lib diet LT-HSCs (comparing A to C) and increases further the ST-HSC number generated by PF-treated LT-HSCs (comparing B to D). These results confirm the role of LT-HSCs in mediating PF-dependent hematopoietic regeneration but also indicate that niche cells exposed to PF can contribute to the ST-HSC component of this regeneration in vitro.
Reduction of IGF-1 or PKA Signaling Promotes HSC Self-Renewal PKA has conserved proaging roles in yeast and mammals (Fabrizio et al., 2001; Rinaldi et al., 2010) . In yeast, integration of an extra copy of the regulatory and inhibitory subunit of PKA, BCY1 (BCY1oe) enhanced, whereas mutations in BCY1 that activate PKA decreased, cellular resistance to H 2 O 2 -induced oxidative stress ( Figure 6A ) in agreement with our previous results with RAS2-and adenylate cyclase-deficient mutants (Fabrizio et al., 2003; Fabrizio et al., 2001) . In mammalian cells, it was confirmed by us and others that disruption of PKA signaling protects against stress ( Figures S5A-S5C ) (Yan et al., 2007) . The role of PKA in hematopoietic regeneration, however, is poorly understood. It is known that PKA negatively regulates Foxo1 and positively regulates CREB and G9a Gonzalez and Montminy, 1989; Yamamizu et al., 2012a) . FoxOs maintain hematopoietic stress-resistance, self-renewal and lineage homeostasis (Tothova et al., 2007) , whereas CREB and G9a promote hematopoietic lineage commitment and differentiation (Chen et al., 2012; Yamamizu et al., 2012b) . We found that in PF mice, the reduction of IGF-1/pAkt and PKA/pCREB signaling was associated with an induction of Foxo1 expression and a reduction of G9a ( Figures 6B and  S5E ), but it did not affect the expressions of Foxo3a and Foxo4 ( Figures S5F-S5H) . Also, the results indicated that the numbers of ST-HSC and MPP were significantly increased after treatment with PKA small interfering RNA (siRNA) as well as after treatment with IGF-1 siRNA (Figures 6C and S5D ; Table S5 ), in agreement with the finding that inhibition of G9a increases primitive HSCs (Chen et al., 2012) .
Given that inhibition of mTOR, another key effector of nutrient signaling, is known to enhance HSC self-renewal and maintenance autonomously and nonautonomously, we examined the crosstalk between mTOR and PKA in HSCs and MPPs (Chen et al., 2009; Huang et al., 2012) . Ex vivo rapamycin (an mTOR inhibitor) treatment alone did not cause an induction in the number of HSCs as expected based upon previous studies with in vivo treatments ( Figure 6C ) (Nakada et al., 2010; Yilmaz et al., 2012) . This could be due to the need for a longer period of mTOR inhibition to achieve HSC induction (Nakada et al., 2010) . In fact, when cotreated with PKA siRNA, rapamycin caused an additional induction in ST-HSC and MPP, compared to that caused by PKA knockdown alone suggesting that diminished PKA signaling promotes the induction of HSCs, which can be further potentiated by mTOR inhibition in certain stem and progenitor cell subpopulations ( Figure 6C) . Notably, the double inhibition of PKA and mTOR resulted in the synergistic induction in ST-HSC and MPP but blunted the induction in LT-HSC caused by PKA knockdown alone, which is similar to what was caused by IGF-R knockdown ( Figure 6C ), and in agreement with the potential role for IGF-1 in the regulation of both PKA and mTOR in HSCs (Fontana et al., 2010; Longo and Fabrizio, 2002) .
The BM cells treated with IGF-1R siRNA or PKA siRNA ex vivo (exBM) were further transplanted into the irradiated recipient mice to assess their hematopoietic reconstitution capacity. In agreement with the effects observed in PF mice, the PKA or IGF-1R-deficient BM cells caused a significant improvement in engraftment in PB and in BM compared to untreated BM cells (G) Number of lymphocytes and myeloid cells in young (6 months, 48 hr fasting) and old (18 months, eight cycles of fasting) mice. For (F) and (G), *p < 0.05, **p < 0.01, and ***p < 0.005, one-way ANOVA.
Fasting Inhibits IGF-1/PKA to Promote Regeneration (Std) ( Figure 6D ). The long-term repopulation capacity was also confirmed by secondary transplantation ( Figure S5I ).
DISCUSSION
When considering changes in gene expression and metabolism, as well as the levels of various hormones, PF promotes coordinated effects that would be difficult to achieve with any pharmacological or other dietary intervention. In yeast, the key changes responsible for the protective effects of starvation are the downregulation of the glucose-sensing Ras/adenylate cyclase/PKA and of the amino acid-sensing Tor/Sch9 (S6K) pathways ( Figure 7A ) (Fontana et al., 2010) . When mutations in both pathways are combined, cells are extremely resistant to a wide variety of toxins and can live up to 5-fold longer than normal (Fabrizio et al., 2001; Kaeberlein et al., 2005; Kenyon, 2001; Longo and Finch, 2003; Wei et al., 2009) . In mammals, mutations that cause deficiency in the GHR-IGF-1 axis promote a range of phenotypes that overlap with those in the highly protected yeast with deficiencies in nutrient signaling pathways including dwarfism, stress resistance, and longevity extension ( Figure 7A ) (Lee and Longo, 2011) . In fact, cells from GHR/ IGF-1-deficient mice are protected from multiple forms of stress (Brown-Borg et al., 2009; Salmon et al., 2005) and the IGF-1-deficient (LID) mice, with an over 70% reduction in circulating IGF-1, are resistant to several chemotherapy drugs (Lee et al., 2010) . Here, we connect the GHR-IGF-1 and the PKA proaging pathways by showing that PKA functions downstream of IGF-1 to sensitize BM cells in agreement with results in yeast and with the previously established connection between IGF-1 and PKA in mammalian neuronal cells (Subramaniam et al., 2005) . However, the studies of growth-deficient yeast and mice could not have predicted the remarkable effect of PF cycles in promoting stem cell-based regeneration of the hematopoietic system. Calorie intake was previously shown to affect the balance of stem cell self-renewal and differentiation, which is important for somatic maintenance and long-term survival (Bondolfi et al., 2004; Chen et al., 2003; Ertl et al., 2008; Jasper and Jones, 2010; Rafalski and Brunet, 2011; Rando and Chang, 2012) . In mice, chronic calorie restriction (CR) promotes the self-renewal of intestinal stem cells, muscle stem cell engraftment and neural regeneration, preserves the long-term regenerative capacity of HSCs, and prevents the decline of HSC number during aging in certain mouse strains (Lee et al., 2002; Bondolfi et al., 2004; Cerletti et al., 2012; Chen et al., 2003; Ertl et al., 2008; Rafalski and Brunet, 2011; Yilmaz et al., 2012) . Reduction of mTOR signaling has been implicated as one of the major molecular mechanisms responsible for the effects of CR on enhanced stem cell function (Huang et al., 2012; Rafalski and Brunet, 2011; Yilmaz et al., 2012) . However, neither CR nor other dietary intervention had previously been shown to promote a coordinated effect leading to the regeneration and/or rejuvenation of a major portion of a system or organ.
Because during PF mammalian organisms minimize energy expenditure in part by rapidly reducing the size of a wide range of tissues, organs, and cellular populations including blood cells, the reversal of this effect during refeeding represents one of the most potent strategies to regenerate the hematopoietic and possibly other systems and organs in a coordinated manner. Here, we show that PF causes a major reduction in WBC number, followed, during refeeding, by a coordinated process able to regenerate this immune system deficiency by changes beginning during the fasting period, which include a major increase in LT-HSC and ST-HSC and redirection of the frequency of Ly-HSC/Bala-HSC/My-HSC leading to a lineage-balanced mode. In fact, we show that PF alone causes a 28% decrease WBC number, which is fully reversed after refeeding ( Figures 7B and  S2F ). Even after WBCs are severely suppressed or damaged as a consequence of chemotherapy or aging, cycles of PF are able to restore the normal WBC number and lineage balance, suggesting that the organism may be able to exploit its ability to regenerate the hematopoietic system after periods of starvation, independently of the cause of the deficiency ( Figure 7B ).
In agreement with our results, starvation protects germline stem cells (GSCs) and extends reproductive longevity in C. elegans through an adaptive energy shift toward the less committed cells (Angelo and Van Gilst, 2009 ). In contrast, short-term fasting (%24 hr) in Drosophila promotes the differentiation of hematopoietic progenitors to mature blood cells (Shim et al., 2012) . It will be important to determine whether the coordinated regenerative changes observed during PF and refeeding may resemble at least in part the sophisticated program responsible for the generation of the hematopoietic system during development.
Recent studies revealed that HSCs rely heavily on the metabolic programs that prevent aerobic metabolism to maintain their quiescent state and self-renewal capacity (Ito et al., 2012; Takubo et al., 2013; Yu et al., 2013) . In the case of PF, the energy metabolism is switched progressively from a carbohydratebased to a fat-and ketone body-based catabolism, which could 
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Fasting Inhibits IGF-1/PKA to Promote Regeneration contribute to HSC self-renewal, in agreement with findings that fatty acid oxidation promotes HSC asymmetric self-renewal over the symmetric commitment (Ito et al., 2012) .
PKA is known to promote lineage specification of HSC through CREB and G9a (Chen et al., 2012; Yamamizu et al., 2012b) . As inhibition of G9a has been a key strategy to promote reprogramming (Huangfu et al., 2008; Shi et al., 2008) , the PFinduced downregulation of G9a shown here may redirect cell fate through a similar process causing the induction in HSCs, analogously to that caused by G9a inhibition ( Figure 5B ) (Chen et al., 2012) . Recent studies also indicate that PKA can directly phosphorylate and negatively regulate FoxO1 , which has a profound role in stem cell stress resistance, self-renewal and pluripotency maintenance (Tothova et al., 2007; Zhang et al., 2011) . Whereas PKA is implicated in stem cell differentiation, our study suggests that cycles of PF downregulate IGF-1 and PKA to promote stem cell selfrenewal.
A therapeutic challenge of hematopoietic regeneration is to stimulate stem cell production for immediate tissue repair while + progenies generated by the purified LT-HSCs exposed to the indicated niche cells. Cells were grown in the contacting coculture system for 3 days and then analyzed by FACS. Error bars represent SEM. *p < 0.05, **p < 0.01, and ***p < 0.005, t test for (A) and one-way ANOVA for (C).
Fasting Inhibits IGF-1/PKA to Promote Regeneration avoiding stem cell depletion under stress (Pang et al., 2011) . Our results indicate that cycles of an extreme dietary intervention represent a powerful mean to modulate key regulators of cellular protection and tissue regeneration but also provide a potential therapy to reverse or alleviate the immunosuppression or immunosenescence caused by chemotherapy treatment and aging, respectively, and possibly by a variety of diseases affecting the hematopoietic and immune systems and other systems and organs. The clinical data shown here provide preliminary results supporting the possibility that these effects can also be translated into effective clinical applications.
EXPERIMENTAL PROCEDURES
Mice C57BL/6J mice (Jackson Laboratory) were used in this study. Mice are either fasted for 48 hr or fed ad libitum before chemotherapy treatment. Cyclophosphamide (CP) was administered intraperitoneally (i.p.) at the dose of 200 mg/kg every 12-14 days (six cycles total). IGF-1 was injected (i.p.) at the dose of 100 mg/kg, twice a day. Six-to 8-week-old B6.SJL mice (Taconic) were used as recipient mice in the competitive repopulation assay. Genotyping for GHRKO mice was performed as shown in Figure S3A . All animal experiments were done in accordance with the USC Institutional Animal Care and Use Committee and NIH guidelines.
Comet Assay DNA damage (including single-stranded DNA and double-stranded DNA breaks) in freshly collected blood and bone marrow (BM) cells was assessed by CometAssay (Trevigen) with a Nikon Eclipse TE300 fluorescent microscope and analyzed with the Comet Score (TriTek, v.1.5). One hundred to two hundred cells were scored per experimental sample.
Complete Blood Count
Peripheral blood (PB) was collected via tail bleeds into heparinized microhematocrit capillary tubes (Fisher Scientific) was and analyzed using BC-2800 Auto Hematology Analyzer (Mindray). CBC profiles from clinical 
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Fasting Inhibits IGF-1/PKA to Promote Regeneration trial were obtained from phase I clinical trial NCT00936364, approved by USC Institutional Review Boards (IRBs) (http://clinicaltrials.gov/show/ NCT00936364).
Competitive Repopulation Assay BM collection and transplantation were performed as previously described (Adams et al., 2007) . Briefly, BM cells were collected from mice (C57B/6J) treated with six cycle CP. BM cells (2.5 3 10 5 ) from CP-treated mice were mixed with an equal number of those from a wild-type competitor mouse (B6.SJL) and injected into recipient B6.SJL, lethally irradiated 24 hr previously with 10 Gy of radiation. The relative contribution of engraftment from the different cell sources was assessed by flow cytometry of the PB with CD45.2 (C57B/6) and CD45.1 (B6.SJL) antigens. , and MPPs (LSK CD48 + CD150 À ) in BM were performed as previously described ( Figure S1 ) (Adams et al., 2007; Challen et al., 2010 was collected from tail vein. Fifty to one hundred microliters of blood was diluted 1:1 with PBS and incubated with anti-CD45.1, anti-CD45.2 antibodies, and anti-CD11b (BD Biosciences). Analysis was performed with BD FACS diva on LSR II.
FACS Analysis
BrdU Incorporation
For detecting cell genesis, mice were injected (i.p.) with the filter sterilized BrdU 2.0% solution (Sigma) at 0.1 mg/g body weight in PBS, twice a day, for 2 days, starting after 24 hr of prolonged fasting (PF mice). BM cells were collected and stained with anti-BrdU combining with the plasma membrane marker antibodies as mentioned above and analyzed on BD FACS diva on an LSR II, according to the manufacturer's protocol (BD Biosciences).
Oxidative Stress Assay for Yeast Day 3 cells were diluted to an OD 600 of 1 in K-phosphate buffer (pH 6) and treated with 50 or 100 mM hydrogen peroxide for 30 min. Serial dilutions of untreated and treated cells were spotted onto YPD plates and incubated at 30 C for 2-3 days.
Cell Culture and Treatments
Cell lines and primary cells used in this study were cultured at 37 C and 5% CO 2. Mouse embryonic fibroblast with overexpressed human IGF1R (R + cells)
were derived from IGF1R knockout mice (obtained from Dr. Baserga) and cultured in DMEM/F12 supplemented with 10% fetal bovine serum (FBS). Cells were seeded at 80% (R + cells) or 50% (exBM or hAFSCs) confluence for IGF-1R and PKACa siRNA transfection (100 nM, with 1% X-tremeGENE transfection reagents, Roche) and/or rapamycin treatment (5 nM), and the inhibition efficiencies of the target proteins are shown in Table S5 . The IGF-1 induction (10 nM, 15 min) was performed at 24 hr after standard incubation. CREB phosphorylation was measured by immunocytochemistry (ICC) with the pCREB-AF488 antibody (cell signaling, 1:200, overnight at 4 C). Explanted BM cells,
